Presence of acute hepatitis D infection in HBsAg positive cancer patients: A preliminary study from west Gujarat

Presence of acute hepatitis D infection in HBsAg positive cancer patients: A preliminary study from west Gujarat

Background & objectives: Hepatitis delta virus (HDV) and hepatitis B virus (HBV) co-infection is well known to induce a spectrum of acute and chronic liver diseases. There has been global decline in the prevalence of hepatitis D infection. The aim of the present study was to know the presence of...

Full description

Bibliographic Details
Main Authors:	Foram Maulin Patel, Parijath N Goswami
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-01-01
Series:	Indian Journal of Medical Research
Subjects:	Hepatitis B virus - hepatitis D virus - hepatocellular carcinoma - seroprevalence
Online Access:	http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2016;volume=143;issue=6;spage=798;epage=800;aulast=Patel

Similar Items

Seroprevalence of HBsAg, Anti-HBs, anti-HDV and HDVAg in Inonu University Medical Faculty Hospital, 2012 [Inonu Universitesi Tip Fakultesi Hastanesinde, 2012 Yilinda, HBsAg, Anti-HBs, Anti-HDV ve HDVAg Seroprevalansi]
by: Yucel Duman, et al.
Published: (2014-03-01)

HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection
by: Imme Roggenbach, et al.
Published: (2021-09-01)

Evaluation of Risk Factors Associated with HBsAg and Anti- HCV Seropositivity: Results of a Nationwide Population-based Epidemiological Survey Study in Turkey
by: Selma TOSUN, et al.
Published: (2018-12-01)

Clinical features of HBsAg-negative HBV-related hepatocellular carcinoma
by: MA Yan, et al.
Published: (2017-04-01)

HBsAg loss with HBsAg/anti-HBs seroconversion and non-detectable HCV-RNA in a patient with chronic HBV e-minus/HCV hepatitis treated with two cycles of antiviral therapy
by: Antonio Salvio, et al.
Published: (2012-01-01)

HBsAg clearance in chronic hepatitis B patients with add-on pegylated interferon alfa-2a to ongoing tenofovir treatment: A randomized controlled study
by: Hamad Al Ashgar, et al.
Published: (2017-01-01)

Cloning of HBsAg Gene of Hepatitis B Virus in to an Expression Vector
by: Aykut ÖZDARENDELİ, et al.
Published: (2003-09-01)

Seroprevalence of HBsAg, Anti-HBs, Anti-HCV and Anti-HIV in Behçet’s Disease
by: Esma Eroğlu, et al.
Published: (2021-05-01)

Quantitative HBsAg levels do not identify hepatic fibrosis in HBeAg-negative chronic hepatitis B patients
by: Fatima A Ahmed, et al.
Published: (2019-01-01)

Comparison of hepatitis E virus seroprevalence between HBsAg-positive population and healthy controls in Shandong province, China
by: Li Zhang, et al.
Published: (2018-02-01)

Seroprevalence of hepatitis B surface antigen (HBsAg) in Bo, Sierra Leone, 2012–2013
by: Rashid Ansumana, et al.
Published: (2018-02-01)

Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg)
by: Catana, A.M, et al.
Published: (2022)

Expression of Hepatitis B virus surface antigen (HBsAg) from genotypes A, D and F and influence of amino acid variations related or not to genotypes on HBsAg detection
by: Natalia M. Araujo, et al.

Hepatitis B Virus-Related Glomerulonephritis with Positive and Negative Serum HBsAg: Different Clinicopathologic Characteristics of Two Clinical Subtypes
by: Yu F, et al.
Published: (2021-06-01)

Clinical analysis of liver injury and hepatitis B virus reactivation after chemotherapy in HBsAg-positive patients with malignant tumors
by: WU Shengxi, et al.
Published: (2016-01-01)

Hepatitis A Virus and Hepatitis E Virus Seroprevalence in Izmir
by: Hale Kalfaoğlu, et al.
Published: (2017-03-01)

Seroprevalence of Hepatitis B and C markers at the population level in the municipality of Caxias do Sul, southern Brazil
by: Débora Menegol, et al.
Published: (2013-12-01)

In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy
by: Robert L. Kruse, et al.
Published: (2017-12-01)

Recombinant HBsAg Vaccine in Persons with HIV: Is Seroconversion Sufficient for Long-term Protection?
by: Powis, Jeff
Published: (2010)

Recombinant HBsAg Vaccine in Persons with HIV: Is Seroconversion Sufficient for Long-term Protection?
by: Powis, Jeff
Published: (2010)

Phylogenetic analysis of HDV isolates from HBsAg positive patients in Karachi, Pakistan
by: Perveen Shadab, et al.
Published: (2012-08-01)

Association between HBsAg clearance and serum level of granulocyte-macrophage colony stimulating factor in inactive HBsAg carriers receiving pegylated interferon alpha-2a
by: CAO Zhenhuan, et al.
Published: (2018-05-01)

Anti-HIV seropositivity was related to HBsAg seropositivity among injecting drug users in Taiwan
by: Meng-Hsuan Hsieh, et al.
Published: (2016-02-01)

The Seroprevalence of Hepatitis B, C and E Viruses Among the Dustmen in Izmir
by: Ali Ilgın OLUT, et al.
Published: (2004-12-01)

Association of HBsAg mutation patterns with hepatitis B infection outcome: Asymptomatic carriers versus HCC/cirrhotic patients
by: Seyed Y. Hosseini, et al.
Published: (2019-07-01)

Using the Quantitative Determination of HBsAg to Monitor the Natural History of Chronic HBV-Infection
by: I.A. Zaitsev
Published: (2015-09-01)

A Case Report of Hepatocellular Carcinoma 5 Years After HBsAg Loss in Chronic Hepatitis Delta: How Long Surveillance is Required?
by: Laura Escolà-Vergé, et al.
Published: (2017-07-01)

Complete genome analysis of hepatitis B virus in Qinghai-Tibet plateau: the geographical distribution, genetic diversity, and co-existence of HBsAg and anti-HBs antibodies
by: He Liu, et al.
Published: (2020-06-01)

Co-infection of Hepatitis A and Hepatitis E Viruses among the Acute Viral Hepatitis Cases in Tertiary Care Hospital –A Four Years Retrospective Study
by: Ravindra V. Shinde, et al.
Published: (2020-09-01)

Hepatitis C Infection among Health Care Workers in Aswan: Seroprevalence and Risk Factors
by: Shaimaa S. Abdelrheem, et al.
Published: (2020-04-01)

Hepatitis A seroprevalence in patients who admitted to a training and research hospital in Southeast Anatolia
by: Hakan Temiz, et al.
Published: (2015-12-01)

Incidental detection of hepatitis B and C viruses and their coinfection in a hospital-based general population in tertiary care hospital of Uttar Pradesh
by: Loveleena Agarwal, et al.
Published: (2018-01-01)

Factors related to duration of serum HBsAg in patients with acute hepatitis B
by: ZHANG Jiawei
Published: (2014-11-01)

Seroprevalence of Hepatitis B and Hepatitis C Virus in HIV/AIDS Patients at Gaziantep University
by: Ahmet Şahin, et al.
Published: (2016-12-01)

The prevalence of HBsAg and Anti-HCV in pregnant women in Adıyaman
by: Servet Kölgelier, et al.
Published: (2009-01-01)

Hepatitis E Virus Seroprevalence among Adults, Germany
by: Mirko S. Faber, et al.
Published: (2012-10-01)

Seroprevalence and Associated Factors of Hepatitis B and C Virus Among Pulmonary Tuberculosis Patients Attending Health Facilities in Gondar Town, Northwest Ethiopia
by: Getie B, et al.
Published: (2021-09-01)

Seroprevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in patients undergoing nasopharyngeal biopsy
by: Muhammet Yildiz, et al.
Published: (2020-12-01)

Evaluation of serum AFP (α-fetoprotein) level in HBsAg carrier patients for diagnosis of hepatocellular carcinoma
by: eskandar Hajiani, et al.
Published: (2006-06-01)

HBsAg in Cord Blood Qf Newborns of HBsAg-Positive Mothers
by: Adnan S. Wiharta, et al.
Published: (2018-11-01)